By Bhanvi Satija LONDON, April 29 (Reuters) - British drugmaker GSK reported first-quarter profit and sales above analysts' expectations on Wednesday, helped by strong demand for its respiratory ...

Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...

By Bhanvi Satija LONDON, April 29 (Reuters) - GSK posted first-quarter profit and sales above analyst expectations on ...

By Bhanvi Satija LONDON, April 29 (Reuters) - Strong first-quarter results under new GSK CEO Luke Miels on Wednesday failed to impress investors, who raised concerns that the British drugmaker's ...

(Reuters) -GSK raised its 2025 sales and earnings expectations on Wednesday after third-quarter results beat forecasts, helped by double-digit growth for its HIV and cancer drugs. This is CEO Emma ...

By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker will aim to lift sales growth and speed up work on new medicines in its ...

GSK Plc is planning five simultaneous late-stage trials for a cancer drug it hopes will be a blockbuster, as new Chief Executive Officer Luke Miels tries to revitalize a company not known for its risk ...

GSK Plc’s new chief executive officer plans to speed up research and development and look for acquisitions as the British drugmaker tries to convince investors it can offset a looming patent cliff.